Design, structure and biological activity of β-turn peptides of CD2 protein for inhibition of T-cell adhesion

European Journal of Biochemistry

Volumn 271, Issue 14, 2004, Pages 2873-2886

  Jining, Liu ^a   Makagiansar, Irwan ^b   Yusuf Makagiansar, Helena ^b   Chow, Vincent T K ^a   Siahaan, Teruna J ^b   Jois, Seetharama D S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

turn; CD2; Cyclic peptide; E rosetting; LFA 3 (CD58)

Indexed keywords

CD2 ANTIGEN; CYCLOPEPTIDE; EPITOPE; GLUTAMYLARGINYLGLYCYLSERYLTHREONYLLEUCINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; TYROSYLSERYLTHREONYLASPARAGINYLGLYCYLTHREONINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING SITE; CELL ADHESION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; E ROSETTE; HUMAN; HUMAN CELL; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ROSETTE FORMATION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD2; ANTIGENS, CD58; CELL ADHESION; CELL LINE, TUMOR; EPITOPES; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RATS; SEQUENCE ALIGNMENT; T-LYMPHOCYTES;

EID: 3242795792     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04198.x     Document Type: Article

References (40)

1. Bierer, B.E. & Burakoff, S.J. (1988) T cells adhesion molecules. FASEB J. 2, 2584-2590.
2. Wang, J.H. & Reinherz, E. (2000) Structure basis of cell-cell interactions in the immune system. Curr. Opin. Structural Biol. 10, 656-661.
3. Kim, M., Sun, Z.Y.J., Byron, O., Campbell, G., Wagner, G., Wang, J.-H. & Reinherz, E.L. (2001) Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional 'hot spot'. J. Mol. Biol. 312, 711-720.
4. Davis, S.J. & van der Merwe, P.A. (1996) The structure and ligand interactions of CD2: implications for T cell function. Immunol. Today 17, 177-187.
5. Bachmann, M.F., Barner, M. & Kopf, M. (1999) CD2 sets quantitative thresholds in T cell activation. J. Exp. Med. 190, 1383-1391.
6. Mojcik, C.F. & Shevach, E. (1997) Adhesion molecules: a rheumatologic perspective. Arthritis Rheumatism 6, 991-1004.
7. Kaplon, R.J., Hochman, P.S., Michler, R.E., Kwiatkowski, P.A., Edwards, N.M., Berger, C.L., Xu, H., Meier, W., Wallner, B.P., Chisholm, P. & Marboe, C.C. (1995) Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardias allograft survival. Transplantation 61, 356-363.
8. Sultan, P., Scheduler, J.S., McNiff, J.M., Hochman, P.S., Hughes, C.C.W., Lorber, M.I., Askenase, P.W. & Pober, J.S. (1997) Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nature Biotechnol. 15, 759-762.
9. Qin, L.H., Chavin, K.D., Lin, J.X., Yagita, H. & Bromberg, J.S. (1994) Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J. Exp. Med. 179, 341-346.
10. Hirahara, H., Tsuchida, M., Wanatabe, T., Haga, M., Matsumoto, Y., Abo, T. & Eguchi, S. (1995) Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 59, 85-90.
11. Sido, B., Otto, G., Zimmermann, R., Müller, P., Meuer, S. & Dengler, T.J. (1996) Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation CD48 (CD2 ligand) in the rat. Transpl. Int. 9, S323-S327.
12. Sido, B., Otto, G., Zimmermann, R., Müller, P., Meuer, S. & Dengler, T.J. (1997) Modulation of the CD2 receptor and not disruption of the CD2/CD48 interaction is the principal action of CD2-mediated immunosuppression in the rat. Cell. Immunol. 182, 57-67.
13. Aruffo, A. & Hollenbaugh, D. (2001) Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease. Curr. Opin. Immunol. 13, 683-686.
14. Przepiorka, D., Phillips, G.L., Ratanatharathorn, V., Michele, C.F., Sehn, L.H., Antin, J.H., Lebherz, D., Awwad, M., Hope, J. & McClain, J.B. (1998) A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood 92, 4066-4071.
15. Branco, L., Barren, P., Mao, S.Y., Pfarr, D., Kaplon, R., Psotema, C., Langermann, S., Koenig, S. & Johnson, S. (1999) Selective deletion of antigen-specific, activated T cells by a humanized mAb to CD2 (MEDI-507) is mediated by NK cells. Transplantation 68, 1588-1596.
16. Albert-Wolf, M., Meuer, S.C. & Wallich, R. (1991) Dual function of recombinant human CD58: inhibition of T-cell adhesion and activation via the CD2 pathway. Int. Immunol. 3, 1335-1347.
17. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 5, 55-63.
18. Bax, A. & Davis, D.G. (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
19. 1H NMR spectra of protein via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479-485.
20. Bax, A. & Davis, D.G. (1985) Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63, 207-213.
21. Kumar, A., Wagner, G., Ernst, R.R. & Wuthrich, K. (1981) Buildup rates of the nuclear Overhauser effect measured by two-dimensional proton magnetic resonance spectroscopy. J. Am. Chem. Soc. 103, 3654-3658.
22. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113, 967-974.
23. Wûthrich, K. (1986) NMR of Proteins and Nucleic Acids. John Wiley & Sons, New York.
24. 2+ binding cyclic peptide derived from the α-subunit of LFA-1: inhibitor of ICAM-1/LFA-1 mediated T-cell adhesion. J. Peptide Res. 53, 18-29.
25. Sutcliffe, M.J., Structure determination from, NMR data. II. Computational approaches. In NMR of Macromolecules: a Practical Approach (Roberts, G.C.K. ed.), pp. 359-390. Oxford University Press, New York.
26. Srinivasan, N., Sowdhamini, R., Ramakrishnan, C. & Balaram, P. (1990) Stereochemical modeling of disulflde bridges. Criteria for introduction into proteins by site-directed mutagenesis. Int. J. Peptide Protein Res. 36, 147-155.
27. Liu, H., Banville, D.L., Basus, V.J. & James, T.L. (1995) Deriving accurate interproton distances for ROESY spectra with limited knowledge of scalar coupling constants via the carnival algorithm: an iterative complete-relaxation-matrix approach. J. Magn. Reson. 107, 51-59.
28. Bystov, V.F. (1976) Spin-spin coupling and the conformational states of peptide systems. Progr. NMR Spectrosc. 10, 41-81.
29. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K. & Olson, A.J. (1998) Automatic docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Compu. Chem. 19, 1639-1662.
30. Wang, J.H., Smoluar, A., Tan, K., Liu, J.H., Kim, M., Sun, Z.Y.J., Wagner, G. & Reinherz, E.L. (1999) Structure of a heterophilic adhesion complex between human CD2 and CD58 (LFA-3) counter-receptors. Cell 97, 791-803.
31. Rose, G.D., Gierasch, L.M. & Smith, J.A. (1985) Turns in peptides and proteins. Adv. In Protein Chem. 37, 1-97.
32. Hetenyi, C. & Van Der Spoel, D. (2002) Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci. 11, 1729-1737.
33. Ikemizu, S., Sparks, L.M., van der Merwe, A., Stuart, D.I., Jones, E.Y. & Davis, S.J. (1999) Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8 Å resolution. Proc. Natl Acad. Sci. USA 96, 4289-4294.
34. Bodian, D.L., Jones, E.Y., Harlos, K., Stuart, D.I. & Davis, S.J. (1994) Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure 2, 755-766.
35. Withka, J.M., Wyss, D.F., Wagner, G., Arulanandam, A.R.N., Reinherz, E.L. & Recny, M.A. (1993) Structure of the glycosylated adhesion domain of human T lymphocye glycoprotein CD2. Structure 1, 69-81.
36. Jones, E.Y., Davis, S.J., Williams, A.F., Harlos, K. & Stuart, D.I. (1992) Crystal structure at 2.8 Å resolution of soluble form of the cell adhesion molecule CD2. Nature 360, 232-239.
37. Sun, Z.Y.J., Dõtsch, V., Kim, M., Li, J., Reinherz, E.L. & Wagner, G. (1999) Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies. EMBO J. 18, 2941-2949.
38. Huang, Z., Li, S. & Korngold, R. (1997) Immunoglobulin superfamily proteins: Structure, mechanisms, and drug discovery. Biopolymers 43, 367-382.
39. Olson, G.L. (1990) Design and synthesis of a protein beta-turn mimetic. J. Am. Chem. 112, 323-333.
40. Tibbetts, S.A., Jois, S.D.S., Siahaan, T.J., Benedict, S.H. & Chan, M.A. (2000) Linear and cyclic LFA-1 and ICAM-1 peptides inhibit T cell adhesion and function. Peptides 21, 1161-1167.